Sarcopenia in the elderly

Family Practice

Volumn 29, Issue SUPPL. 1, 2012, Pages

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ageing; Geriatric medicine; Muscle strength

Indexed keywords

25 HYDROXYVITAMIN D; ACTIVIN RECEPTOR 2; ANABOLIC AGENT; ANDROGEN RECEPTOR; CILIARY NEUROTROPHIC FACTOR; CREATINE; CYCLIN DEPENDENT KINASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; ESSENTIAL AMINO ACID; GHRELIN; GROWTH HORMONE; HORMONE RECEPTOR AFFECTING AGENT; HYBRID PROTEIN; INTERLEUKIN 6; LEUCINE; MYOSTATIN; NANDROLONE; NITRIC OXIDE; OSTARINE; PERINDOPRIL; PROTEIN; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADL DISABILITY; AGED; AGING; ARTICLE; BONE DENSITY; CALORIC INTAKE; DIET SUPPLEMENTATION; EDEMA; FOOD INTAKE; FRAIL ELDERLY; HUMAN; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PROTEIN SYNTHESIS; RESISTANCE TRAINING; TESTOSTERONE RELEASE; UNSPECIFIED SIDE EFFECT; WEIGHT LIFTING;

AGED; AGING; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; MUSCLE STRENGTH; SARCOPENIA; TESTOSTERONE;

EID: 84858246427     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmr063     Document Type: Article

References (37)

1. Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging 2008; 12: 452-6.
2. Janssen I. Evolution of sarcopenia research. Appl Phsyiol Nutr Metab 2010; 35: 707-12.
3. Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 2010; 95: 139-59.
4. Morley JE. Anorexia, sarcopenia and aging. Nutrition 2001; 17: 660-5.
5. Rolland Y, Lauwers-Cances V, Cristini C et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'Osteoporose) Study. Am J Clin Nutr 2009; 89: 1895-900.
6. Fried LP, Ferrucci L, Darer J et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59: 255-63.
7. Bauer JM, Kaiser MJ, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008; 9: 545-51.
8. Morley JE. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009; 15: 3384-95.
9. Abellan van Kan G, Rolland YM, Morley JE, Vellas B. Frailty: toward a clinical definition. J Am Med Dir Assoc 2008; 9: 71-2.
10. Abellan van Kan G, Rolland Y, Bergman H et al. The I.A.N.A. Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008; 12: 29-37.
11. Rolland Y, Czerwinski S, Abellan van Kan G et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008; 12: 433-50.
12. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle 2010; 1: 129-33.
13. Janssen I,Heymsfield SB,RossR. Low relative skeletal muscle mass (sarcopenia) in older persons is associatedwith functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-96.
14. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc 2006; 54: 56-62.
15. Baumgartner RN, Wayne SJ, Waters DL et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12: 1995-2004.
16. von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachex Sarcopenia Muscle 2010; 1: 1-5.
17. Fearon K, Evans WJ, Anker SD. Myopenia-a new universal term for muscle wasting. J Cachex Sarcopenia Muscle 2011; 2: 1-3.
18. Morley JE, Argiles JM, Evans WJ et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010; 11: 391-6.
19. Millward DJ, Fereday A, Gibson NR et al. Efficiency of utilization of wheat and milk protein in healthy adults and apparent lysine requirements determined by a single-meal [1-13C] leucine balance protocol. Am J Clin Nutr 2002; 76: 1326-34.
20. Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci 2003; 58: 11-9.
21. Perry HM, Miller DK, Patrick P, Morley JE. Testosterone and leptin in olderAfrican-Americanmen: relationship to age, strength, function and season. Metabol Clin Exper 2000; 49: 1085-91.
22. Haren MT, Siddiqui AM, Armbrecht HJ et al. Testosteronemodulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle. Int J Androl 2010; doi:10.1111/j.1365-2605.2010.01061.x.
23. Wang C, Nieschlag E, Swerdloff R et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008; 159: 507-14.
24. Morley JE. Anabolic steroids and frailty. J Am Med Dir Assoc 2010; 11: 533-6.
25. Morley JE. Wieght loss in older presons: new therapeutic approaches. Curr Pharm Des 2007; 13: 3637-47.
26. Chapman IM, Visvanathan R, Hammond AJ et al. Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. Am J Clin Nutr 2009; 89: 880-9.
27. Nass R, Johannsson G, Christiansen JS, Kopchick JJ, Thomer MO. The aging population-is there a role for endocrine interventions? Growth Horm IGF Res 2009; 19: 89-100.
28. Musaro A, Giacinti C, Borsellino G et al. Stemcell-mediatedmuscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci U S A 2004; 101: 1206-10.
29. Perry HM III, Horowtiz M, Morley JE et al. Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism 1999; 48: 1028-32.
30. Morley JE. Vitamin D redux. J Am Med Dir Assoc 2009; 10: 591-2.
31. Glass D, Roubenoff R. Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci 2010; 1211: 25-36.
32. Haren MT, Malmstrom TK, Miller DK et al. Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a crosssectional analysis of a cohort of late middle-aged African Americans. J Gerontol A Biol Sci Med Sci 2010; 65: 274-81.
33. Jang YC, Van Remmen H. Age-associated alterations of the neuromuscular function. Exp Gerontol 2010 September 16; [Epub ahead of print].
34. Sayer AA. Sarcopenia. BMJ 2010; 341: c4097.
35. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-23.
36. Fielding RA, Vellas B, Evans WJ et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-56.
37. Morley JE, Abbatecola AM, Argiles JM et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011; 12: 403-9.